ライフサイエンスコーパス: deficiency anemia

1 worldwide whose inadequate diet causes iron deficiency anemia.

2 atients with unexplained, mild, chronic iron-deficiency anemia.

3 causing gastrointestinal blood loss and iron deficiency anemia.

4 owing: osteoporosis or low bone mass or iron-deficiency anemia.

5 further characterization of this novel SOD2-deficiency anemia.

6 ted with a 40% reduction in the risk of iron deficiency anemia.

7 the benefits of successful treatment of iron deficiency anemia.

8 ause of gastrointestinal hemorrhage and iron deficiency anemia.

9 ues, while they continue to have severe iron deficiency anemia.

10 s cause gastrointestinal hemorrhage and iron deficiency anemia.

11 males and significantly associated with iron deficiency anemia.

12 onsidered for children with nutritional iron-deficiency anemia.

13 and education were not associated with iron deficiency anemia.

14 HFE mutations had a lower prevalence of iron deficiency anemia.

15 %) were iron deficient; 24 of these had iron deficiency anemia.

16 r patients with rheumatoid arthritis or iron-deficiency anemia.

17 000 toddlers and 3.3 million women have iron deficiency anemia.

18 be a safe and efficacious treatment for iron deficiency anemia.

19 , whose mutations cause iron refractory iron deficiency anemia.

20 llenge the entrenched oral treatment of iron deficiency anemia.

21 ited States who do not have symptoms of iron deficiency anemia.

22 orders had been treated for concomitant iron deficiency anemia.

23 ary hemochromatosis and iron-refractory iron-deficiency anemia.

24 /L; P<0.05) and low in one patient with iron deficiency anemia.

25 appeared to be effective in correcting iron deficiency anemia.

26 important biomarker in diseases such as iron-deficiency anemia.

27 underlies erythropoietic repression in iron deficiency anemia.

28 nths of age in infants at high risk for iron deficiency anemia.

29 His blood count shows signs of mild iron deficiency anemia.

30 e Tg mice exhibited hepcidin excess and iron deficiency anemia.

31 elevated hepcidin levels and consequent iron deficiency anemia.

32 inguishes thalassemia-trait anemia from iron-deficiency anemia.

33 aining regimens with iron deficiency or iron deficiency anemia.

34 tion of abnormal hemoglobin to classify iron deficiency anemia.

35 children, including iron deficiency and iron deficiency anemia.

36 05) in volunteers reporting to BCT with iron deficiency anemia.

37 6 with secondary erythrocytosis, 2 with iron-deficiency anemia, 4 with hemochromatosis, or 5 normal s

38 tical improvements in the management of iron deficiency anemia, a disorder that may affect as many as

39 ons in predictors of iron deficiency or iron deficiency anemia according to iron supplementation sugg

40 tensity infection had a greater risk of iron deficiency anemia (adjusted prevalence odds ratio: 6.6;

41 Iron deficiency anemia afflicts 1 in 3 individuals, mostly wo

42 one has determined the prevalence of folate-deficiency anemia after fortification.

43 The odds of iron deficiency anemia among children aged 12-15 y were 2.95

44 for successful interventions to reduce iron deficiency anemia among food-insecure children and to im

45 study compared 96 female patients with iron-deficiency anemia and 60 healthy female control subjects

46 rther evaluation, from which those with iron-deficiency anemia and active bleeding had been excluded,

47 e of the tendency of infants to develop iron deficiency anemia and because of the documented adverse

48 ctive was to estimate the prevalence of iron deficiency anemia and examine potential reasons for this

49 els were used to identify predictors of iron deficiency anemia and iron deficiency without anemia.

50 ation of the potential contributions of iron deficiency anemia and iron treatment to this differentia

51 Hookworm infection is a major cause of iron deficiency anemia and malnutrition in developing countri

52 Fe deficiency anemia and the anemia of inflammation may co-

53 is gastroenterologist for evaluation of iron deficiency anemia and weight loss.

54 Both children were diagnosed with iron deficiency anemia and were suspected to have an associat

55 ointestinal blood loss, and unexplained iron-deficiency anemia), and the performance of selected test

56 The disease can additionally lead to vitamin deficiencies, anemia, and osteoporosis.

57 Fifty-two percent of the subjects had iron deficiency anemia, and 30% had serum 25-hydroxyvitamin D

58 enty-five percent of all anemia, 35% of iron deficiency anemia, and 73% of severe anemia were attribu

59 f iron fortification of food to improve iron deficiency, anemia, and biological outcomes is not prove

60 stores and decreasing the prevalence of iron deficiency, anemia, and vitamin A deficiency.

61 tanding type II diabetes, hypertension, iron deficiency anemia, aortic stenosis, and prior bariatric

62 teropathy being a consequence of severe iron deficiency anemia are discussed.

63 trics recommendations for prevention of iron deficiency anemia are reviewed.

64 Iron deficiency and iron deficiency anemia are still relatively common in toddler

65 Poor iron status and iron deficiency anemia are the hallmarks of hookworm disease.

66 fect in iron absorption that results in iron-deficiency anemia, as revealed by an N-ethyl-N-nitrosour

67 ficiency among children worldwide, with iron-deficiency anemia associated with long-term adverse neur

68 erritin levels and a lower incidence of iron-deficiency anemia at 4-6 months of age.

69 nd ferritin level, iron deficiency, and iron deficiency anemia at 8 and 12 months of age.

70 comes that are associated with maternal iron deficiency anemia, both Canada and the United States rec

71 One infant developed iron deficiency anemia by 5.5 mo of age.

72 .48; 95% CI, 0.32-0.70) and the risk of iron deficiency anemia by 66% (RR, 0.34; 95% CI, 0.19-0.62).

73 mia of chronic disease, iron refractory iron deficiency anemia, cancer, hereditary hemochromatosis, a

74 Four of 8 of the deprived monkeys had iron deficiency anemia compared with none of the controls and

75 is the most accurate animal model of folate deficiency anemia described to date that closely capture

76 6; CI: 0.4, 0.7), but the prevalence of iron deficiency anemia did not change significantly in childr

77 mice and Belgrade (b) rats have severe iron deficiency anemia due to defects in intestinal iron tran

78 She had a history of iron-deficiency anemia due to long-standing celiac disease th

79 for both groups and no infant developed iron deficiency anemia during the trial.

80 re undetectable or low in patients with iron deficiency anemia (ferritin < 10 ng/mL), iron-depleted H

81 en aged 9 to 48 months with nutritional iron-deficiency anemia, ferrous sulfate compared with iron po

82 n and its great value in distinguishing iron deficiency anemia from the anemia of chronic disease.

83 deficiency (from 60% to 6%; P<0.0001), iron deficiency anemia (from 35% to 15%; P<0.007), and abnorm

84 Patients with iron-deficiency anemia had a significantly reduced choroidal

85 India's high prevalence of iron-deficiency anemia has largely been attributed to the loc

86 Iron-deficiency anemia (IDA) affects millions of persons worl

87 theast Asia, Thalassemia trait (TT) and iron deficiency anemia (IDA) are the two most common anemia t

88 Although the hazards associated with iron deficiency anemia (IDA) are well known, concerns about r

89 Iron deficiency anemia (IDA) has detrimental effects on indiv

90 workup fails to establish the cause of iron deficiency anemia (IDA) in a substantial proportion of p

91 utine screening and supplementation for iron deficiency anemia (IDA) in asymptomatic, nonanemic pregn

92 he actual prevalence of anemia, ID, and iron deficiency anemia (IDA) in California remains unclear.

93 tween Helicobacter pylori infection and iron deficiency anemia (IDA) in humans.

94 itis-induced achlorhydria is a cause of iron deficiency anemia (IDA) in humans.

95 in anemia of chronic disease (ACD) and iron deficiency anemia (IDA) in patients with RA.

96 is associated with iron deficiency and iron-deficiency anemia (IDA) in the United States.

97 The prevalence of iron deficiency anemia (IDA) increased over the malaria seaso

98 When detected early in pregnancy, iron deficiency anemia (IDA) is associated with a > 2-fold in

99 d young children in Sub-Saharan Africa, iron-deficiency anemia (IDA) is common, and many complementar

100 Iron deficiency anemia (IDA) is relatively common in the thir

101 Preoperative iron deficiency anemia (IDA) occurs frequently; however if le

102 Iron deficiency anemia (IDA) still remains universally proble

103 prevalence of iron deficiency (ID) and iron deficiency anemia (IDA) was 10-32% and 2-5%, respectivel

104 the prevalence of iron deficiency (ID), iron deficiency anemia (IDA), and other measures of iron nutr

105 d on iron biomarker concentrations were iron deficiency anemia (IDA), anemia of inflammation (AI), an

106 tin, which was suitable for identifying iron-deficiency anemia (IDA), but less reliable than serum as

107 at delivery, and 25% (n = 5) developed iron deficiency anemia (IDA).

108 bout half of this burden is a result of iron deficiency anemia (IDA).

109 ciency (ID; diminished iron stores) and iron deficiency anemia (IDA; poor iron stores and diminished

110 evere complications that may arise from iron deficiency anemia if it is not recognized and treated ea

111 ion at the locus, impacting the risk of iron deficiency anemia in African Americans with specific gen

112 The treatment of iron deficiency anemia in children with inflammatory bowel di

113 ongest predictor of iron deficiency and iron deficiency anemia in children.

114 iagnostic panel for iron deficiency and iron deficiency anemia in children.

115 ion is associated with growth delay and iron deficiency anemia in developing countries.

116 enting and treating iron deficiency and iron deficiency anemia in infants and young children.

117 for determining hemoglobin cutoffs for iron deficiency anemia in other populations.

118 offer a new, efficient option to treat iron deficiency anemia in patients with CKD.

119 priate for estimating the prevalence of iron deficiency anemia in poor Jamaican girls 13-14 y of age.

120 Current knowledge indicates that iron deficiency anemia in pregnancy is a risk factor for pret

121 pregnant women or routine screening for iron deficiency anemia in pregnant women or young children.

122 of benefits and harms of screening for iron deficiency anemia in pregnant women to prevent adverse m

123 todes, are currently a leading cause of iron deficiency anemia in the developing world.

124 imate prevalence of iron deficiency and iron deficiency anemia in the Jamaican girls: 7.6% and 4.3%,

125 rostate 3 (Steap3), responsible for the iron deficiency anemia in the mouse mutant nm1054.

126 and iron overload, iron deficiency, or iron deficiency anemia in the U.S. population.

127 ine protease mutated in iron-refractory iron deficiency anemia, inhibits hepcidin expression by dampe

128 Iron-refractory, iron-deficiency anemia (IRIDA) is a familial disorder charact

129 amilial anemia disorder iron-refractory iron deficiency anemia (IRIDA).

130 In particular, iron deficiency anemia is a major global health issue, but th

131 Iron deficiency anemia is common and consequential in nondial

132 n low and middle income countries where iron-deficiency anemia is highly prevalent.

133 The prevalence of iron deficiency anemia is likely to be higher in athletic pop

134 The prevalence of iron deficiency anemia is low (3%) among unsupplemented breas

135 acid fortification, the prevalence of folate-deficiency anemia is nearly nonexistent in a community-d

136 Iron deficiency anemia is one of the most serious forms of ma

137 Our results may explain why iron deficiency anemia is the most pronounced early manifesta

138 y significant multivariate predictor of iron deficiency anemia (LRT = 30.43; P<.001).

139 n blood in the small intestine, causing iron-deficiency anemia, malnutrition, growth and development

140 ter (P = 0.038) than did the women with iron deficiency anemia (n = 34).

141 in level, iron-deficiency (IDA) and non-iron-deficiency anemia (NIDA), and inflammatory markers.

142 Summary statistics on iron deficiency anemia, night blindness, and risk of zinc def

143 yroidism, liver disease, AIDS, coagulopathy, deficiency anemia, obesity, alcohol abuse, or drug abuse

144 Patients with documented iron-deficiency anemia or active gastrointestinal bleeding we

145 who are malnourished, have symptoms of iron deficiency anemia, or have special hematologic condition

146 e other major modes of presentation are iron-deficiency anemia, osteoporosis, screening of family mem

147 of SGA birth was lower in subjects with iron deficiency anemia (P = 0.002).

148 ng early development in iron-refractory iron deficiency anemia patients, who present with microcytic

149 Here, we show that iron deficiency anemia refractory to oral iron therapy can be

150 lthough much of the ethnic disparity in iron deficiency anemia remains unexplained, factors associate

151 woman has heavy menstrual bleeding and iron-deficiency anemia.She reports nocturia and urinary frequ

152 ly the microcytic hypochromic anemia or iron deficiency anemia that is the clinical hallmark of hookw

153 kness (CT) in the eyes of patients with iron-deficiency anemia, the most common form of the anemia, v

154 inical trial in adults with NDD-CKD and iron deficiency anemia to compare the safety and efficacy of

155 n levels for diagnosing iron-refractory iron deficiency anemia to global health applications such as

156 n status across the full continuum from iron deficiency anemia to iron deficiency to iron replete to

157 n symptoms of irritable bowel syndrome, iron deficiency anemia, unexplained arthritis, and even chron

158 is a familial disorder characterized by iron deficiency anemia unresponsive to oral iron treatment bu

159 Overall, the prevalence of folate-deficiency anemia was <0.1% (1 of 1546 subjects).

160 iron supplement use, the prevalence of iron deficiency anemia was 2.3 times higher in Mexican Americ

161 ncome) >3.0, however, the prevalence of iron deficiency anemia was 2.6 +/- 0.9% in Mexican American a

162 The prevalence of iron deficiency anemia was 31% in the NI control group compar

163 The prevalence of iron deficiency anemia was 6.2 +/- 0.8% (f1.gif" BORDER="0">

164 Iron deficiency anemia was defined as abnormal results from >

165 Folate-deficiency anemia was defined as the presence of both fo

166 Iron deficiency anemia was defined as the presence of both ir

167 ring age were iron deficient; of these, iron deficiency anemia was found in 3% and 2% to 5%, respecti

168 ongest) predictor of iron deficiency or iron deficiency anemia was lower 6-mo hemoglobin.

169 The prevalence of iron deficiency anemia was lower in women who carried HFE mut

170 st administration of FCM, correction of iron deficiency anemia was observed with improved mean hemogl

171 Iron-deficiency anemia was the top cause globally, although 1

172 e rates of anemia, iron deficiency, and iron deficiency anemia were significantly lower after 24 wk i

173 2.7%) to 6.8% (95% CI: 4.2%, 9.3%), and iron deficiency anemia, which was 6.2% (95% CI: 3.0%, 9.3%) a

174 hat newborn homozygous Pcm mice exhibit iron deficiency anemia with increased duodenal Fpn1 expressio

175 NHANES III classified iron-deficiency anemia with other nutritional anemias, a clas

176 e prevalence of folate deficiency and folate-deficiency anemia within a sample of the Reasons for Geo

177 ith reduced risk of iron deficiency and iron deficiency anemia without a concomitant increase in the